A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer

Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location. In addition, following initial curative therapy, many patients present with limited...

Full description

Bibliographic Details
Main Authors: Pretesh R. Patel, David S. Yoo, Yuzuru Niibe, James J. Urbanic, Joseph K. Salama
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Pulmonary Medicine
Online Access:http://dx.doi.org/10.1155/2012/480961

Similar Items